» Articles » PMID: 38870069

Randomized Double-Blind Study of the Effect of Injectate Temperature on Intrathecal Bupivacaine Dose Requirement in Spinal Anesthesia for Cesarean Delivery

Overview
Journal Anesth Analg
Specialty Anesthesiology
Date 2024 Jun 13
PMID 38870069
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Increasing the temperature of intrathecal local anesthetics has been shown to increase the speed of onset and block height of spinal anesthesia. However, how this influences dose requirement has not been fully quantified. The aim of this study was to determine and compare the effective dose for anesthesia for cesarean delivery in 50% of patients (ED 50 ) of intrathecal bupivacaine given at temperatures of 37 °C (body temperature) or 24 °C (room temperature).

Methods: Eighty healthy parturients having elective cesarean delivery under combined spinal-epidural anesthesia were randomly assigned to receive intrathecal hyperbaric bupivacaine stored at 37 °C (body temperature group) or 24 °C (room temperature group). The first subject in each group received a bupivacaine dose of 10 mg. The dose for each subsequent subject in each group was varied with an increment or decrement of 1 mg based on the response (effective or noneffective) of the previous subject. Patients for whom the dose was noneffective received epidural supplementation after data collection with lidocaine 2% as required until anesthesia was sufficient for surgery. Values for ED 50 were calculated using modified up-down sequential analysis with probit analysis applied as a backup sensitivity analysis. These values were compared and the relative mean potency was calculated.

Results: The ED 50 (mean [95% confidence interval, CI]) of intrathecal hyperbaric bupivacaine was lower in the body temperature group (6.7 [5.7-7.6] mg) compared with the room temperature group (8.1 [7.7-8.6] mg) ( P < .05). The relative potency ratio for intrathecal bupivacaine for the room temperature group versus the body temperature group was 0.84 (95% CI, 0.77-0.93).

Conclusions: Warming hyperbaric bupivacaine to body temperature reduced the dose requirement for spinal anesthesia for cesarean delivery by approximately 16% (95% CI, 7%-23%).

References
1.
Chambers W, Edstrom H, Scott D . Effect of baricity on spinal anaesthesia with bupivacaine. Br J Anaesth. 1981; 53(3):279-82. DOI: 10.1093/bja/53.3.279. View

2.
Xiao F, Drzymalski D, Liu L, Zhang Y, Wang L, Chen X . Comparison of the ED50 and ED95 of Intrathecal Bupivacaine in Parturients Undergoing Cesarean Delivery With or Without Prophylactic Phenylephrine Infusion: A Prospective, Double-Blind Study. Reg Anesth Pain Med. 2018; 43(8):885-889. DOI: 10.1097/AAP.0000000000000850. View

3.
Uppal V, Retter S, Casey M, Sancheti S, Matheson K, McKeen D . Efficacy of Intrathecal Fentanyl for Cesarean Delivery: A Systematic Review and Meta-analysis of Randomized Controlled Trials With Trial Sequential Analysis. Anesth Analg. 2019; 130(1):111-125. DOI: 10.1213/ANE.0000000000003975. View

4.
Nazli B, Oguzalp H, Horasanli E, Gamli M, Dikmen B, Gogus N . The effects on sensorial block, motor block, and haemodynamics of levobupivacaine at different temperatures applied in the subarachnoid space. Biomed Res Int. 2014; 2014:132687. PMC: 3977099. DOI: 10.1155/2014/132687. View

5.
MacPherson H . Pragmatic clinical trials. Complement Ther Med. 2004; 12(2-3):136-40. DOI: 10.1016/j.ctim.2004.07.043. View